ce180274fa3ba3db5c10ecbd9ae2479d4816e972
max
Tue Mar 10 04:00:45 2026 -0700
Add MPRAVarDB track: 239k MPRA-tested regulatory variants from 18 studies
Convert MPRAVarDB CSV (Wang et al. 2024) to bigBed9+ with liftOver of
hg19 variants to hg38. Color by significance (red=FDR<0.05, orange=p<0.05,
grey=not significant). MouseOver shows ref/alt/cell line/log2FC/p/FDR.
Track added to existing MPRAs superTrack, refs #34284
Co-Authored-By: Claude Opus 4.6
+The MPRAs super track contains tracks with results from
+Massively Parallel Reporter Assays (MPRA), high-throughput experimental methods
+that test thousands of genetic variants for their effects on gene regulation.
+
+The MPRAVarDB track shows 242,818 variants from 18 MPRA studies compiled
+in the MPRAVarDB database
+(Wang et al., 2024).
+Each variant was experimentally tested in an MPRA experiment to evaluate whether it
+affects transcriptional regulatory activity. The database covers over 30 cell lines
+and 30 human diseases and traits, including neurodegenerative diseases, immune
+disorders, melanoma, multiple myeloma, and autoimmune diseases.
+
+Items are colored by statistical significance:
+Description
+MPRAVarDB
+Display Conventions
+
+
+
+Each item shows the variant name (rsID when available, otherwise chr:pos:ref>alt), +the reference and alternate alleles, the associated disease or trait, cell line, +log2 fold change, p-value, and FDR. +
+ ++The following table lists the 18 MPRA studies included in MPRAVarDB, with the number of +tested variants, diseases/traits, cell lines, and a brief description of the variant selection. +
+ +| Study | +Variants | +Disease/Trait | +Cell Line(s) | +Description | +
|---|---|---|---|---|
| Griesemer et al., 2021 | +72,588 | +NHGRI-EBI GWAS catalog | +GM12878, HEK293FT, HMEC, HepG2, K562, SKNSH | +3'UTR SNPs and indels in LD with GWAS catalog variants, variants under positive selection, and rare outlier expression variants from GTEx | +
| Kircher et al., 2019 | +44,647 | +Various (18 diseases including diabetes, cancer, blood disorders, limb malformations) | +HEK293T, HEL92.1.7, HaCaT, HeLa, HepG2, K562, LNCaP, MIN6, NIH/3T3, Neuro-2a, SK-MEL-28, SF7996 | +Saturation mutagenesis of 20 disease-associated regulatory elements at single base-pair resolution | +
| Abell et al., 2022 | +29,582 | +eQTL (no specific disease) | +GM12878 | +30,893 variants in LD with independent, common, top-ranked eQTL across 744 eGenes in the CEU cohort | +
| Tewhey et al., 2016 | +27,138 | +eQTL (no specific disease) | +GM12878 | +32,373 variants associated with eQTLs in lymphoblastoid cell lines | +
| Schuster et al., 2023 | +26,546 | +Prostate cancer | +PC3 | +14,497 single-nucleotide mutations enriched in oncogenic pathways and 3'UTR regulatory elements | +
| Mouri et al., 2022 | +14,551 | +Autoimmune diseases (Crohn's, IBD, psoriasis, MS, RA, T1D, ulcerative colitis) | +Jurkat | +GWAS variants from autoimmune disease loci tested for regulatory element activity in T cells | +
| McAfee et al., 2023 | +10,310 | +Schizophrenia | +HEK293s, HNPS | +5,173 fine-mapped schizophrenia GWAS variants | +
| Cooper et al., 2022 | +5,340 | +Alzheimer's disease, Progressive supranuclear palsy | +HEK293T | +5,706 noncoding SNVs from 25 AD and 9 PSP genome-wide significant loci | +
| Long et al., 2022 | +3,980 | +Melanoma | +C283T, UACC903 | +1,992 risk-associated variants in tight LD (r2>0.8) from 54 melanoma risk loci | +
| Myint et al., 2020 | +2,158 | +Schizophrenia, Alzheimer's disease | +K562, SH-SY5Y | +1,049 SZ and 30 AD variants in 64 SZ loci and 9 AD loci | +
| Choi et al., 2020 | +1,664 | +Melanoma | +HEK293FT, UACC903 | +GWAS melanoma risk variants | +
| Ajore et al., 2022 | +1,582 | +Multiple myeloma | +L363, MOLP8 | +1,039 variants in high LD (r2>0.8) at 23 MM risk loci | +
| Klein et al., 2019 | +1,119 | +Osteoarthritis | +Saos-2 | +1,605 SNPs in high LD (r2>0.8) at 35 lead SNPs associated with OA via GWAS | +
| Lu et al., 2021 | +1,038 | +Systemic lupus erythematosus | +GM12878, Jurkat | +18,312 variants in tight LD (r2>0.8) with 578 GWAS index variants at 531 loci | +
| Mulvey & Dougherty, 2021 | +275 | +Major depressive disorder | +N2A | +Over 1,000 SNPs from 39 neuropsychiatric GWAS loci, selected by overlap with eQTL and histone marks | +
| Ferraro et al., 2020 | +150 | +Rare variant expression (no specific disease) | +GM12878 | +Rare variants contributing to extreme expression, allelic expression, and splicing across 49 GTEx tissues | +
| Rao et al., 2021 | +88 | +Alcohol use disorder | +BLA, CE, NAC, SFC | +SNPs in 3'UTR of 88 genes from allele-specific expression analysis (30 AUD subjects vs 30 controls) | +
| Ulirsch et al., 2016 | +62 | +Red blood cell traits | +K562, K562+GATA1 | +2,756 variants in strong LD with 75 sentinel variants associated with RBC traits | +
+Data was downloaded from the
+MPRAVarDB web server.
+Variants originally mapped to hg19 (213,689 of 242,818) were lifted to hg38
+using liftOver. 114 variants could not be mapped and were excluded.
+The remaining variants were merged with the 29,129 natively hg38-mapped variants
+to produce a total of 239,028 hg38 records.
+
+The raw data can be explored interactively with the
+Table Browser or the
+Data Integrator.
+The data can also be accessed from the command line using
+bigBedToBed.
+
+Thanks to Tao Wang and colleagues at the University of Florida for creating and +maintaining the MPRAVarDB database. +
+ ++Wang T, Matreyek KA, Yang X. + +MPRAVarDB: an online database and web server for exploring regulatory effects of genetic variants using MPRA data. +Bioinformatics. 2024 Apr 15;40(4):btae201. +PMID: 38617248; +PMC: PMC11014600 +